Colony formation assay
The PLC/PRF/5 and Huh7 spheres were dissociated as described above. Trypan blue staining was used to determine cell viability, and more than 95% of cells with viability were acceptable for the following experiments. The single cells were seeded in DMEM with 10% FBS at a density of 2000 cells/well on 6-well plates that were pre-coated with Matrigel (BD Biosciences, San Jose, CA, USA). After 2 weeks, the colony formation ability was assessed by counting the number of colonies (> 70 cells) under a microscope after crystal violet staining (SigmaAldrich, St. Louis, MO, USA). Representative views were photographed. The parental cells were plated at the same density as the control.
Transwell migration assay
The invasion assay was performed using 24-transwell chambers (Costar, Bodenheim, Germany).
Briefly, the parental adherent monolayer, tumor sphere SMMC-7721, PLC/PRF/5 and Huh7 cells or 20 uM DATP/15 uM XAV939 treated sphere cells were resuspended in serum-free DMEM. The upper chamber was loaded with 2 × 10 4 cells/100 µl suspension and the lower chamber was loaded with 500 µl DMEM with 15% FBS. Following culture for 36 h, the cells in the upper chamber were removed and the lower chamber filter was fixed with 4% paraformaldehyde and stained with crystal violet. The number of cells that migrated to the undersurface of the membrane was counted and six randomly selected fields were analyzed. Three independent experiments were performed.
In vivo tumorigenicity experiments
All animal experiments were approved by the Institutional Animal Care and Use Committee of the Huazhong University of Science and Technology, which in according with the U.S. Public Health Service Policy on Use of Laboratory Animals. The PLC/PRF/5 parental and the third passage of sphere-forming cells with or without 10 μM DMSO, 20 μM DATP or 15 μM XAV939 pretreated for 7 days were used in tumorigenicity experiments. various numbers of viable single cells were subcutaneously injected into 5-week-old NOD/SCID male mice (animal centre of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) in serum-free DMEM/Matrigel (1:1) using 100 μl microsyringe. Tumor-bearing mice and controls housed in the Animal Institute of Tongji Medical College in laminar flow cabinets for 45 days and sacrificed. The length (L) and width (W) of the tumors were measured externally with a vernier caliper every 3 days. Tumor volume was calculated with the formula: V = (L × W 2 )/2. Then the tumors were harvested for further examination.
RNA isolation, quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from cultured cells using TRIzol reagent (Invitrogen) and cDNA was synthesized from 100 ng RNA using PrimeScript RT reagent Kit (Takara, Japan). Real-time quantitative PCR using SYBRP remix (TaKaRa) was performed as described previously [6] . Amplifications were performed in a Step One Real-Time PCR system (Applied Biosystems, USA) following the manufacturer's instructions. The expression of RNA was determined from the threshold cycle (Ct) and the relative expression levels were calculated by the 2-∆∆Ct method. All samples were assayed in triplicate. The primer sequences used to amplify specific target genes are listed in Supplementary Table S5 .
Western blotting analysis and immunofluorescence
Quantified protein (40 μg) were separated on 8%-12% SDS-PAGE and were electrophoretically transferred onto nitrocellulose membranes (Millipore), which were blocked in PBST containing 5% milk for 2 hours at RT and immuno-blotted with the primary antibodies against full-length (FL)Notch1 (1:1000, CST), Cleaved Notch1 (Val1744,D3B8, CST), Hes1 (1:1000, CST), anti-Hey1 (1:600, Abcam), β-catenin (1:5000, SIGMA), active-β-Catenin (anti-ABC, 1:500, Millipore), anti-c-Myc (1:1000, CST), anti-CNND1 (1:800, Proteintech Group, Chicago, IL, USA), anti-Nanog (1:1000, CST), anti-Sox2,anti-Oct4,anti-Ecadherin (1:800, Proteintech Group), anti-vimentin (1:500, Proteintech Group), anti-Twist1 (1:800, Proteintech Group), anti-snail(1:1000, CST). The membranes were washed and incubated with horseradish peroxidase-labeled secondary antibody (1:5000; Santa Cruz Biotechnology), visualization was performed by an enhanced chemiluminescence kit (Pierce) and exposure to X-ray film (Kodak, Rochester, NY, USA). Immunoblotting with anti-GAPDH antibody was used as an internal control to confirme quivalent protein loading. Each experiment was repeated three times. Slides were viewed with Olympus Provismicroscope and FV1000 confocal microscope (Olympus). 
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